FI925005A0 - Nya sulfonylfoereningar - Google Patents

Nya sulfonylfoereningar

Info

Publication number
FI925005A0
FI925005A0 FI925005A FI925005A FI925005A0 FI 925005 A0 FI925005 A0 FI 925005A0 FI 925005 A FI925005 A FI 925005A FI 925005 A FI925005 A FI 925005A FI 925005 A0 FI925005 A0 FI 925005A0
Authority
FI
Finland
Prior art keywords
pct
sulfonylfoereningar
nya
date nov
sec
Prior art date
Application number
FI925005A
Other languages
English (en)
Finnish (fi)
Other versions
FI925005L (fi
FI925005A7 (fi
Inventor
Dieter Flockerzi
Hermann Amschler
Volker Figala
Kurt Klemm
Rolf Beume
Dietrich Haefner
Guido Hanauer
Manfrid Eltze
Christian Schudt
Ulrich Kilian
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI925005L publication Critical patent/FI925005L/fi
Publication of FI925005A7 publication Critical patent/FI925005A7/fi
Publication of FI925005A0 publication Critical patent/FI925005A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Heat Treatment Of Steel (AREA)
FI925005A 1990-05-16 1991-05-14 Nya sulfonylfoereningar FI925005A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH165890 1990-05-16
PCT/EP1991/000895 WO1991017991A1 (de) 1990-05-16 1991-05-14 Neue sulfonylverbindungen

Publications (3)

Publication Number Publication Date
FI925005L FI925005L (fi) 1992-11-05
FI925005A7 FI925005A7 (fi) 1992-11-05
FI925005A0 true FI925005A0 (fi) 1992-11-05

Family

ID=4215610

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925005A FI925005A0 (fi) 1990-05-16 1991-05-14 Nya sulfonylfoereningar

Country Status (23)

Country Link
US (1) US5346904A (cs)
EP (1) EP0528922B1 (cs)
JP (1) JP3238397B2 (cs)
CN (1) CN1027507C (cs)
AT (1) ATE181330T1 (cs)
AU (1) AU651592B2 (cs)
CA (1) CA2082923C (cs)
CS (1) CS144791A3 (cs)
DE (3) DE4191109A1 (cs)
DK (1) DK0528922T3 (cs)
ES (1) ES2134777T3 (cs)
FI (1) FI925005A0 (cs)
GR (1) GR3031098T3 (cs)
HU (2) HU9203557D0 (cs)
IE (1) IE911625A1 (cs)
IL (1) IL98133A (cs)
MY (1) MY105344A (cs)
NO (1) NO924414D0 (cs)
NZ (1) NZ238141A (cs)
PT (1) PT97680B (cs)
WO (1) WO1991017991A1 (cs)
YU (1) YU85691A (cs)
ZA (1) ZA913627B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0612247A1 (de) * 1991-11-15 1994-08-31 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung von sulfonylverbindungen
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
GEP20012390B (en) * 1996-11-11 2001-03-25 Byk Gulden Lomberg Chem Fab Benzonaphthyridines as Bronchial Therapeutics
US6143759A (en) * 1997-03-07 2000-11-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrazoles
AU8106598A (en) * 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
CA2295309A1 (en) 1997-06-30 1999-01-07 Nippon Kayaku Kabushiki Kaisha Novel naphthyridine derivatives or salts thereof
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8196556B2 (en) * 2009-09-17 2012-06-12 Delphi Technologies, Inc. Apparatus and method for setting mechanical lash in a valve-deactivating hydraulic lash adjuster
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
US4087530A (en) * 1974-02-05 1978-05-02 Sandoz Ltd. Substituted 6-phenyl-octahydrobenzo [c] [1,6] naphthyridines
FI750205A7 (cs) * 1974-02-05 1975-08-06 Sandoz Ag
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin

Also Published As

Publication number Publication date
DK0528922T3 (da) 1999-11-22
JP3238397B2 (ja) 2001-12-10
IL98133A (en) 1994-11-11
DE4191109D2 (en) 1993-04-01
CA2082923A1 (en) 1991-11-17
MY105344A (en) 1994-09-30
US5346904A (en) 1994-09-13
YU85691A (sh) 1994-06-24
ES2134777T3 (es) 1999-10-16
NO924414L (no) 1992-11-16
ZA913627B (en) 1992-01-29
DE4191109A1 (cs) 1993-04-01
EP0528922B1 (de) 1999-06-16
FI925005L (fi) 1992-11-05
CS144791A3 (en) 1992-03-18
FI925005A7 (fi) 1992-11-05
NZ238141A (en) 1993-07-27
IL98133A0 (en) 1992-06-21
HU9203557D0 (en) 1993-03-29
CN1027507C (zh) 1995-01-25
ATE181330T1 (de) 1999-07-15
JPH05507081A (ja) 1993-10-14
GR3031098T3 (en) 1999-12-31
CA2082923C (en) 2001-12-18
DE59109135D1 (de) 1999-07-22
EP0528922A1 (de) 1993-03-03
HUT62895A (en) 1993-06-28
WO1991017991A1 (de) 1991-11-28
CN1056691A (zh) 1991-12-04
IE911625A1 (en) 1991-11-20
AU7870191A (en) 1991-12-10
PT97680A (pt) 1992-02-28
PT97680B (pt) 1998-09-30
AU651592B2 (en) 1994-07-28
NO924414D0 (no) 1992-11-16

Similar Documents

Publication Publication Date Title
DK0528922T3 (da) Hidtil ukendte sulfonylforbindelser
ATE167476T1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
ATE168101T1 (de) Arylpyridazinone
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
EE9900105A (et) Bensonaftüridiinid bronhiaalravimitena
DE59507755D1 (de) Dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten
FI853624L (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
NO962285D0 (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
TW261614B (cs)
AU7345391A (en) Derivative of beta-phenylisoserine, preparation and utilisation thereof
DK0668852T3 (da) Substituerede orthoethenylphenyleddikesyrederivater
ES2103794T3 (es) Pirazolinas, pirazolidinas e hidrazinas artropodicidas.
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
FI925444A0 (fi) Utgaongsaemnen foer framstaellning av 10b-h-steroider och framstaellning avdessa utgaongsaemnen
FI824155L (fi) Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren
FI952855A0 (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.

Legal Events

Date Code Title Description
FD Application lapsed